Skip to main content
NIH funding notice PAR-19-359

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)

Closed on July 16, 2022.

Posted
August 29, 2019
Close date
July 16, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $83,192 in first-year total cost, median $83,192.

Most frequent study sections

  1. Social Sciences and Population Studies A Study Section[SSPA]1

Most frequent institutions

  1. TEMPLE UNIV OF THE COMMONWEALTH1
Competing awards under PAR-19-359 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Examining the Integrative Effects of Adolescent, Parent, Provider, and Practice Level Factors on Adolescents' HPV Vaccine Uptake across Six Asian American Subgroups1R03CA259633-01A1ZHU, LINTEMPLE UNIV OF THE COMMONWEALTH, PA$83,192SSPA

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.